VANDA PHARMACEUTICALS INC. Debt Securities, Available-for-sale, Noncurrent
VANDA PHARMACEUTICALS INC. (VNDA) had Debt Securities, Available-for-sale, Noncurrent of $61.83 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2019-11-07
- 2019-09-30: Debt Securities, Available-for-sale, Noncurrent $61.83M.
- 2019-06-30: Debt Securities, Available-for-sale, Noncurrent $12.52M.
- 2018-12-31: Debt Securities, Available-for-sale, Noncurrent $0.00.
- 2012-03-31: Debt Securities, Available-for-sale, Noncurrent $0.00.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2019-09-30 | $61.83M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $12.52M 10-Q · filed 2019-08-01 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-07 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-09 |
| 2011-12-31 | $19.01M 10-K · filed 2013-02-26 |
| 2011-09-30 | $19.01M 10-Q · filed 2011-11-07 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |